المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - trimipramine maleate - oral capsule - 50mg

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - lamotrigine - oral tablet - 100mg

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

jiangsu hengrui medicine co., ltd. - daptomycin (unii: nwq5n31vkk) (daptomycin - unii:nwq5n31vkk) - daptomycin for injection is indicated for the treatment of adult patients with complicated skin and skin structure infections (csssi) caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus (including methicillin-resistant isolates), streptococcus pyogenes, streptococcus agalactiae, streptococcus dysgalactiae subsp. equisimilis, and enterococcus faecalis (vancomycin-susceptible isolates only). pediatric use information is approved for merck & co., inc.’s cubicin (daptomycin for injection). however, due to merck & co., inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. daptomycin for injection is indicated for the treatment of adult patients with staphylococcus aureus bloodstream infections (bacteremia), including adult patients with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates. pediatric use information is approved for merck & co., inc.’s cubicin (daptomyci

إسرائيل - الإنجليزية - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - daptomycin - lyophilized powder for solution for injection - daptomycin 500 mg/vial - daptomycin - cubicin is indicated for the treatment of the infections listed below. * complicated skin and skin structure infectionscomplicated skin and skin structure infections (csssi) caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus (including methicillin-resistant isolates), streptococcus pyogenes, streptococcus agalactiae, streptococcus dysgalactiae subsp. equisimilis, and enterococcus faecalis (vancomycin-susceptible isolates only).* staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolatesstaphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates.* combination therapy may be clinically indicated if the documented or presumed pathogens include gram negative or anaerobic organisms

إسرائيل - الإنجليزية - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - daptomycin - lyophilized powder for solution for injection or infusion - daptomycin 350 mg/vial - daptomycin - daptomycin s.k. is indicated for the treatment of the infections listed below. • complicated skin and skin structure infections complicated skin and skin structure infections (csssi) caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus (including methicillin-resistant isolates), streptococcus pyogenes, streptococcus agalactiae, streptococcus dysgalactiae subsp. equisimilis, and enterococcus faecalis (vancomycin-susceptible isolates only).• staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates.• combination therapy may be clinically indicated if the documented or presumed pathogens include gram negative or anaerobic organisms.

إسرائيل - الإنجليزية - Ministry of Health

k.s.kim international ltd - daptomycin - lyophilized powder for solution for injection or infusion - daptomycin 500 mg/vial - daptomycin - daptomycin s.k. is indicated for the treatment of the infections listed below. • complicated skin and skin structure infections complicated skin and skin structure infections (csssi) caused by susceptible isolates of the following gram-positive bacteria: staphylococcus aureus (including methicillin-resistant isolates), streptococcus pyogenes, streptococcus agalactiae, streptococcus dysgalactiae subsp. equisimilis, and enterococcus faecalis (vancomycin-susceptible isolates only).• staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates.• combination therapy may be clinically indicated if the documented or presumed pathogens include gram negative or anaerobic organisms.